| Net Cash Provided by (Used in) Operating Activities |
$99,369,000 |
USD |
-0.18% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$150,490,000 |
USD |
-89% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$42,397,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
125,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
84,233,035 |
shares |
0.74% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$8,773,000 |
USD |
53% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$29,692,000 |
USD |
-23% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$17,731,000 |
USD |
2.7% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$34,936,000 |
USD |
-4.6% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$41,005,000 |
USD |
-1.7% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$203,269,000 |
USD |
-5.4% |
Q3 2025 |
Q3 2025 |
| Depreciation |
$40,100,000 |
USD |
1.5% |
Q1 2025 |
Q1 2025 |
| Deferred Income Tax Expense (Benefit) |
$530,000 |
USD |
-91% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$14,208,000 |
USD |
26% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
25,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$3,972,784,000 |
USD |
0.66% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$132,977,000 |
USD |
4.2% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |